Latest News and Press Releases

AMRYT PHARMA PLC (“Amryt” or the “Company”) Exercise of Warrants & Issue of Ordinary Shares and Total Voting Rights DUBLIN, Ireland, and Boston MA, September 21 2020, Amryt (Nasdaq: AMYT, AIM:...

  AMRYT PHARMA PLC (“Amryt” or the “Company”) AMRYT RECEIVES POSITIVE OPINION FROM EMA ON ORPHAN DRUG DESIGNATION FOR AP103 DUBLIN, Ireland, and Boston MA, September 15 2020,  Amryt (Nasdaq: AMYT,...

  AMRYT PHARMA PLC (“Amryt” or the “Company”) AMRYT ANNOUNCES POSITIVE TOP LINE RESULTS FROM PIVOTAL PHASE 3 “EASE” TRIAL OF FILSUVEZ® IN EPIDERMOLYSIS BULLOSA - Primary endpoint met with...

  AMRYT PHARMA PLC (“Amryt” or the “Company”) NOTIFICATION OF CANCELLATION OF ADMISSION TO EURONEXT GROWTH DUBLIN, Ireland, and Boston MA, August 11, 2020, Amryt, (Nasdaq: AMYT, AIM: AMYT, Euronext...

AMRYT ANNOUNCES Q2 2020 RESULTS AND ISSUES POSITIVE REVENUE GUIDANCE FOR FY 2020 New revenue guidance of $170M - $175M in 2020 Conference call and webcast today 0830 ET / 1330 BST DUBLIN,...

  AMRYT PHARMA PLC (“Amryt” or the “Company”) AMRYT TO HOST KEY OPINION LEADER CALL ON EPIDERMOLYSIS BULLOSA DISEASE LANDSCAPE Monday, August 3, 2020 at 1000 ET / 1500 BST DUBLIN, Ireland, and...

  AMRYT PHARMA PLC (“Amryt” or the “Company”) AMRYT TO ANNOUNCE Q2 RESULTS ON AUGUST 6, 2020 DUBLIN, Ireland, and Boston MA, July 20 2020, Amryt (Nasdaq: AMYT, AIM: AMYT, Euronext Growth: AYP), a...

  THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER OF   SECURITIES IN ANY JURISDICTION THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR IMMEDIATE RELEASE AMRYT PHARMA PLC ...

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER OF SECURITIES IN ANY JURISDICTION AMRYT PHARMA PLC (“Amryt” or the “Company”) POSTING OF ANNUAL REPORT AND NOTICE OF AGM ...

  THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER OF SECURITIES IN ANY JURISDICTION THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR IMMEDIATE RELEASE AMRYT PHARMA PLC...